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Introduction: Percutaneous dilatational tracheostomy (PDT) is one of the most frequent procedures performed in
the intensive care unit (ICU). PDT may add potential benefit to clinical management of critically ill patients. Despite
this, no clinical guidelines are available. We sought to characterize current practice in this international survey.
Methods: An international survey, endorsed and peer reviewed by European Society of Intensive Care Medicine
(ESICM), was carried out from May to October 2013. The questionnaire was accessible from the ESICM website in
the ‘survey of the month’ section.
Results: 429 physicians from 59 countries responded to this survey. Single step dilatational tracheostomy was the
most used PDT in ICU. Almost 75 % of PDT’s were performed by intensive care physicians. The main indication for
PDT was prolonged mechanical ventilation. Tracheostomies were most frequently performed between 7–15 days
after ICU admission. Volume control mechanical ventilation, and a combination of sedation, analgesia,
neuromuscular blocking agents and fiberoptic bronchoscopy were used. Surgical tracheostomy was mainly
performed in ICU by ENT specialists, and was generally chosen when for patients at increased risk for difficult PDT
insertion. Bleeding controlled by compression and stoma infection/inflammation were the most common intra-
procedural and late complications, respectively. Informed consent for PDT was obtained in only 60 % of cases.
Conclusions: This first international picture of current practices in regard to tracheostomy insertion demonstrates
considerable geographic variation in practice, suggesting a need for greater standardization of approaches to
tracheostomy insertion.Introduction
Percutaneous dilatational tracheostomy (PDT) is one of
the most frequent procedures performed in the intensive
care unit (ICU) [1]. PDT may add potential benefit to
clinical management of critically ill patients by increas-
ing patients’ comfort, reducing the need for sedation,
facilitating the weaning process and hastening ICU dis-
charge [2]. Despite this, no clinical guidelines have been
developed to delineate the best practice for this invasive
and potentially risky procedure [3]. Recently the use of a
customized checklist, adapted from the World Health
Organization surgical safety checklist, has been sug-
gested to improve the safety of PDT [4]. However, the
utility of this checklist has not been demonstrated. To* Correspondence: ppelosi@hotmail.com
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article, unless otherwise stated.date, no study has investigated the tracheostomy practice
at a multinational level. This is the first international
survey aiming to evaluate the daily practice of PDT ac-
cording to different settings, operators, types, timing, in-
dications, procedural features, sedation and ventilation
protocols, and intra-procedural, early and late complica-
tions. This survey may show a proof of concept that an
international daily shared clinical practice on PDT tech-
niques is possible.
Materials and methods
The European Critical Care Research Network (ECCRN)
of the European Society of Intensive Care Medicine
(ESICM) endorsed this survey. Ethical approval for this
study was not requested because this was a voluntary
survey and no individual patient data were collected.
The questionnaire (Additional file 1) included 31 ques-
tions organized in two main sections, analyzing: 1) thele is distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
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type, timing, indication, procedural features, sedation
and ventilation protocol, and intra-procedural, early and
late complications of PDT. The questionnaire was vali-
dated by a local panel of experts in intensive care and
then underwent the peer review process by the ESICMTable 1 Baseline characteristics of study respondents
Response rate
Total
Valid respondents 281 (100 %)
Main specialty area
- Intensive care 202/281 (71.9 %)
- Anesthesiology 63/281 (22.4 %)
- Pulmonology 5/281 (1.8 %)
- Cardiology 2/281 (0.7 %)
- Neurology 1/281 (0.4 %)
- Surgery 2/281 (0.7 %)
- Other 6/281 (2.1 %)
Type of institution
- Public hospital 128/281 (45.6 %)
- Private hospital 33/281 (11.7 %)
- University hospital 120/281 (42.7 %)
Type of intensive care
- Cardiac 9/281 (3.2 %)
- Mixed 206/281 (73.3 %)
- Medical 22/281 (7.8 %)
- Neurological 13/281 (4.6 %)
- Surgical 31/281 (11 %)
Number of ICU beds
- ≤ 5 8/281 (2.8 %)
- 6−10 101/281 (35.9 %)
- 11−15 61/281 (21.7 %)
- 16−20 49/281 (17.4 %)
- ≥21 62/281 (22.1 %)
Number of patients/years admitted in ICU
- ≤300 39/281 (13.9 %)
- 301−600 98/281 (34.9 %)
- 601−999 63/281 (22.4 %)
- ≥1000 81/281 (28.8 %)
Different techniques performed
- one 99/281 (35.2 %)
- two 14/281 (49.8 %)
- three 31/281 (11 %)
- four 7/281 (2.5 %)
- five 2/281 (0.7 %)
- six 2/281 (0.7 %)Research Committee. After the acceptance by the
ESICM Research Committee, the survey was carried out
from May to October 2013, and was accessible from the
ESICM website in the ‘survey of the month’ section. All
ESICM members were alerted by email and invited to
complete the survey via the ESICM research updates.Statistics
Europe Outside Europe
208/281 (74 %) 73/281 (26 %) -
147/208 (70.7 %) 55/73 (75.3 %)
51/208 (24.5 %) 12/73 (16.4 %)
3/208 (1.4 %) 2/73 (2.7 %) X2 = 10.810
0 2/73 (2.7 %) P = 0.094
1/208 (0.5 %) 0
1/208 (0.5 %) 1/73 (1.4 %)
3/208 (1.4 %) 1/73 (1.4 %)
105/208 (50.5 %) 23/73 (31.5 %) X2 = 52.573
9/208 (4.3 %) 24/73 (32.9 %) P = 0.000
94/208 (45.2 %) 26/73 (35.6 %)
8/208 (3.8 %) 1/73 (3.8 %)
154/208 (74 %) 52/73 (71.2 %) X2 = 23.108
9/208 (4.3 %) 13/73 (17.8 %) P = 0.000
12/208 (5.8 %) 1/73 (1.4 %)
25/208 (12 %) 6/73 (8.2 %)
7/208 (3.4 %) 1/73 (1.4 %)
84/208 (40.4 %) 17/73 (23.3 %) X2 = 14.942
44/208 (21.2 %) 17/73 (23.3 %) P = 0.011
32/208 (15.4 %) 17/73 (23.3 %)
41/208 (19.7 %) 21/73 (28.8 %)
31/208 (14.9 %) 8/73 (11 %) X2 = 2.517
71/208 (34.1 %) 27/73 (37 %) P = 0.472
44/208 (21.2 %) 19/73 (26 %)
62/208 (29.8 %) 19/7 (26 %)
63/208 (30.3 %) 36/73 (49.3 %)
109/208 (52.4 %) 31/73 (42.5 %) X2 = 19.708
26/208 (12.5 %) 5/73 (6.8 %) P = 0.001
7/208 (3.4 %) 0
2/208 (1 %) 0
1/208 (0.5 %) 1/73 (1.4 %)
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lyzed anonymously.
Submitted questionnaires were excluded from analysis
if the respondents completed section II only. Failure to
answer to one or more questions in section II was not a
reason for exclusion.
The data were evaluated as total distribution of answers
and then divided according to the geographical area of
respondents within Europe (E) and outside Europe (OE)
by using descriptive statistics. Data have been reported as
counts and percentages. The effects of geographical
location on PDT practices were analyzed using the chi-
squared (X2) test for categorical variables or univariate
analysis of variance (ANOVA) for continuous variables.
Data have been weighted for the total number of partici-
pating intensive care units in and outside Europe, to
perform tests of statistical significance. The p value was
set at 0.05. Statistical analysis was performed using SPSS,
version 20.0.Results
Study respondents
Responses were received from 429 physicians from 59
countries (Europe 73.6 %, Asia 15.8 %, America 9.1 %,
Africa 1.0 %, Australia 0.5 %) (Additional file 2). Accord-
ing to our entry criteria, 281 satisfactorily completed
questionnaires from 52 countries (Europe 75.0 %, Asia
16.4 %, America 7.5 %, Africa 0.7 %, Australia 0.4 %)
were included in the final analysis. Of the satisfactorily
completed questionnaires, 75 % (n = 208) came from E
while 25 % (n = 73) were from OE.
Table 1 shows the baseline characteristics of study
respondents. The main specialty area was intensive care
in 71.9 % of respondents (n = 202) followed by
anesthesiology (22.4 %, n = 61). Public hospitals (45.6 %,
n = 128) and university hospitals (42.7 %, n = 120) were
the institutions most involved in the responses from E
but not from OE (E vs OE: X2 = 52.573, p = 0.000). The
type of ICU involved in responses was mixed ICUs (73.3 %,
n = 206) followed by surgical ICUs (11 %, n = 31) from E
but not OE, where medical ICUs (17.8 %, n = 13) followed
mixed ICUs (71.2 %, n = 52) (E vs OE: X2 = 23.108, p =
0.000). The majority of respondents worked in an ICU with
6–10 beds (35.9 %, n = 101) in E but not OE, where the
majority of responses came from ICU with more than 21
beds (28.8 %, n = 21) (E vs OE: X2=14.942, p = 0.011). The
most frequent number of patients admitted to study
ICUs annually was between 301 and 600 (34.9 %, n = 98)
in E and OE (E 34.1 %, OE 37 %, E vs OE: X2 = 2.517,
p = 0.472). Physicians in E performed two tracheostomy
techniques more frequently, while in OE they per-
formed one technique more frequently (E 52.4 %, n = 109;
OE 49.3 %, n = 36; X2 = 19.708, p = 0.001).Tracheostomy
The total number of tracheostomies performed by the
respondents was 17,894, with 74 % (n = 13,220) in E and
26 % (n = 4,764) in OE. Figure 1 shows the distribution
of different tracheostomies. The most frequently per-
formed tracheostomy procedure was the single-step dila-
tion tracheostomy (SSDT) (41.6 %, n = 7,442) followed
by surgical tracheostomy (ST) (24.1 %, n = 4,345). The
most frequently performed tracheostomy procedure in E
was the SSDT (46.6 %, n = 6,160) while OE it was the
ST (36.4 %, n = 1,733).Informed consent
Informed patient/substitute decision-maker consent for
tracheostomy was obtained in 61.2 % (n = 172) of par-
ticipating ICUs. The informed consent was obtained
more frequently OE than in E (informed consent ob-
tained: OE 87.7 %, n = 64; E 51.9 %, n = 108; informed
consent not obtained: OE 12.3 %, n = 9; E 48.1 %, n =
100; X2 = 49.332, p = 0.000).Percutaneous dilatational tracheostomy (PDT)
Table 2 describes the variations in approach to the per-
formance of PDT in ICUs across the world. PDT in the
ICU was more often performed by (one or more) inten-
sivists (74 %, n = 208). The most frequent indication for
PDT was prolonged mechanical ventilation (53.7, 151)
followed by difficult or prolonged weaning 24.2 %, n =
68). The most frequent timing of PDT was between 7 and
15 days (54.4 %, n = 153). The majority of respondents
used volume control ventilation during PDT (42.3 %, n =
119) insertion. Almost 80 % of respondents administered
a combination of sedation, analgesia, and neuromuscular
blockade to patients undergoing PDT insertion. Propofol
was the most commonly used sedative overall (85.4 %, n =
240), with 92.3 % (n = 192) in E and 65.8 % (n = 48) OE.
Fentanyl and remifentanil were the most used analgesic
drugs overall, while fentanyl and morphine were the most
used OE. Cis-atracurium and rocuronium were the neuro-
muscular blocking agents most used overall and in E,
while atracurium and vecuronium were the most used
OE. Local anesthesia was provided by 64.9 % (n = 179) of
respondents. Bronchoscopy during PDT was used more
frequently overall (69.2 %, n = 180); its use was more fre-
quent in European ICUs than OE. Bronchoscopy during
PDT was most often performed through the endotracheal
tube (ETT) in place (86.9 %, n = 232), followed by the re-
placement of a larger ETT (6 %, n = 16) or laryngeal mask
airway (LMA) 6 %, n = 16). The most used bronchoscope
had a diameter of 5 mm overall (39.1 %, n = 86) and in E
(42.9 %, n = 72) and 6 mm OE (38.5 %, n = 20). The bron-
choscope was chosen more frequently according to the
availability in the ICU (63.8 %, n = 143). Neck ultrasound
Fig. 1 Distribution of different tracheostomies shown as the total number performed in and outside Europe. *Statistically significant. MDT
multiple dilation tracheostomy, SSDT single-step dilation tracheostomy, GWDF guidewire dilating forceps, RDT rotational dilation tracheostomy,
BDT balloon dilation tracheostomy, TLT translaryngeal tracheostomy, ST surgical tracheostomy
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structures were considered to be at increased risk of injury
(68.6 %, n = 81). A cuffed tube was the most frequently
chosen tracheostomy tube at the end of the procedure
(45.9 %, n = 118).
Surgical tracheostomy
Table 3 describes the use of surgical tracheostomy (ST)
in the ICU. STs were performed more frequently in the
critically ill in ICU (59.1 %, n = 166), with only 15.6 %
undergoing ST in the operation room (OR). In the OR,
ST was performed more frequently by ear-nose-throat
(ENT) specialists (59.7 %, n = 165) followed by general
surgeons (14.9 %, n = 42). ST was more often reserved
for patients who were deemed to be at higher risk of
difficult PDT insertion (70.1 %, n = 187).
Complications
The most frequent intra-procedural and early complications
in E and OE was bleeding controlled by compression at 31.7
% (n = 89) followed by ETT puncture 20.2 % (n = 52).
Bleeding requiring exploration was reported to be the most
frequent late complication (33.1 %, n = 85). Table 4 shows
the intra-procedural, early and late complications.
Discussion
This is the first international survey investigating the
current spectrum of clinical practice in tracheostomyinsertion in critically ill patients. In this investigation we
found that single-step dilatational tracheostomy was the
most frequent PDT approach used in the ICU. Intensive
care physicians mainly performed PDT for prolonged
mechanical ventilation. Consistent with this, the most
popular timing for tracheostomy was between 7 and 15
days after ICU admission. Volume control mechanical
ventilation, sedation-analgesia-neuromuscular blocking
agents, local anesthesia and fiber optic bronchoscope
were most frequently used during the procedure. ST was
also frequently performed in critically ill patients. In this
survey ST was mainly performed in the ICU by ENT
specialists and was often chosen in cases where PDT
was predicted to be difficult. In regard to complication
arising from tracheostomy, our findings suggest that
bleeding controlled by compression and stoma infection/
inflammation were the most common intra-procedural
and late complications, respectively. There was consider-
able variability in regard to practices surrounding in-
formed consent for tracheostomy in critically ill patients,
with informed consent for PDT obtained in only 60 % of
cases.
This is the first survey investigating the international
clinical practice for PDT in critically ill patients, because
previous surveys have been national investigations per-
formed in European countries [5–12]. In addition, none
of the previous surveys reported information about PDT
performed outside Europe. In this survey 26 % of
Table 2 Procedural features of percutaneous dilatational tracheostomy performed in the intensive care unit
Response rate Statistics
Total Europe Outside Europe
Who performed PDT in ICU
- One or more intensivists 208/281 (74 %) 166/208 (79.8 %) 42/73 (57.5 %)
- Intensivist with ENT specialists 16/281 (5.7 %) 10/208 (4.8 %) 6/73 (8.2 %)
- Intensivist with general surgeon 6/281 (2.1 %) 1/208 (0.5 %) 5/73 (6.8 %) X2 = 51.732
- Intensivist with other surgeon 8/281 (2.8 %) 5/208 (2.4 %) 3/73 (4.1 %) P = 0.000
- Anesthesiologist 18/281 (6.4 %) 17/208 8.2 %) 1/73 (1.4 %)
- ENT specialists 15/281 (5.3 %) 7/208 (3.4 %) 8/73 (11 %)
- General surgeon 7/281 (2.5 %) 1/208 (0.5 %) 6/73 (8.2 %)
- Another surgeon 3/281 (1.1 %) 1/208 (0.5 %) 2/73 (2.7 %)
Most frequent indication
- Prolonged mechanical ventilation 151/281 (53.7 %) 107/208(51.4 %) 44/73 (60.3 %)
- Difficult/prolonged weaning 68/281 (24.2 %) 55/208 (26.4 %) 13/73 (17.8 %) X2 = 9.039
- Neurocritical disease (medical, disease,
surgical or trauma involving the neurologic system)
41/281 (14.6 %) 32/208 (15.4 %) 9/73 (12.3 %) P = 0.171
- Inability to perform airway protection 12/281 (4.3 %) 8/208 (3.8 %) 4/73 (5.5 %)
- Inability to cough and swallow 5/281 (1.8 %) 4/208 (1.9 %) 1/73 (1.4 %)
- Improvement of patient respiratory mechanics 3/281 (1.1 %) 1/208 (0.5 %) 2/73 (2.7 %)
- Copious secretions 1/281 (0.4 %) 1/208 (0.5 %) 0
Most frequent timing
- <7days 55/281 (19.6 %) 47/208 (22.1 %) 9/73 (12.3 %)
- 7–15 days 153/281 (54.4 %) 108/208 (51.9 %) 45/73 (61.6 %) X2 = 9.707
- 15–21 days 58/281 (20.6 %) 43/208 (20.7 %) 15/73 (20.5 %) P = 0.046
- 21–30 days 11/281 (3.9 %) 7/208 (3.4 %) 4/73 (5.5 %)
- >30 days 4/281 (1.4 %) 4/208 (1.9 %) 0
Mechanical ventilation mostly used
- Volume control ventilation 119/281 (42.3 %) 84/208 (40.4 %) 35/73 (47.9 %)
- Pressure control ventilation 102/281 (36.3) 75/208 (36.1 %) 27/73 (37 %)
- Minute volume/adaptive support
ventilation
13/281 (4.6 %) 12/208 (5.8 %) 1/73 (1.4 %) X2 = 15.504
- Bi-level airway pressure 34/281 (12.1 %) 30/208 (14.4 %) 4/73 (5.5 %) P = 0.004
- Other 13/281 (4.6 %) 7/208 (3.4 %) 6/73 (8.2 %)
Sedation-analgesia-neuromuscular
blocking protocol provided
- Yes 221/278 (79.5 %) 163/207 (78.7 %) 58/71 (81.7 %) X2 = 0.456
- No 57/278 (20.5 %) 44/207 (21.3 %) 13/71 (18.3 %) P = 0.500
Local anesthesia provided
- Yes 179/276 (64.9 %) 124/206 (60.2 %) 55/70 (78.6 %) X2 = 12.859
- No 97/276 (35.1 %) 82/206 (39.8 %) 15/70 (21.4 %) P = 0.000
Bronchoscopy used during PDT
- Yes 180/260 (69.2 %) 153/194 (78.9 %) 39/66 (59.1 %) X2 = 48.827
- No 80/260 (30.8 %) 41/194 (21.1 %) 27/66 (40.9 %) P = 0.000
Bronchoscopy during PDT performed
- Through ETT in place 232/267 (86.9 %) 176/201(87.6 %) 56/66 (84.8 %)
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Table 2 Procedural features of percutaneous dilatational tracheostomy performed in the intensive care unit (Continued)
- Replacement with larger ETT 16/267 (6 %) 12/201 (6 %) 4/66 (6.1 %) X2 = 0.807
- Replacement with smaller ETT 3/267 (1.1 %) 2/201 (1 %) 1/66 (1.5 %) P = 0.848
- Through LMA 16/267 (6 %) 11/201 (5.5 %) 5/66 (7.6 %)
- Diameter of bronchoscope used
- 3–4 mm 40/220 (18.2 %) 34/169 (20.2 %) 6/52 (11.5 %)
- 5 mm 86/220 (39.1 %) 72/169 (42.9 %) 14/52 (26.9 %) X2 = 17.268
- 6 mm 65/220 (29.5 %) 45/169 (26.8 %) 20/52 (38.5 %) P = 0.001
- 7 mm 29/220 (13.2 %) 17/169 (10.1 %) 12/52 (23.1 %)
- ≥8 mm 0 0 0
Bronchoscope was chosen
- According to availability in ICU 143/224 (63.8 %) 110/171 (64.3 %) 33/53 (62.3 %)
- According the size of ETT in place 51/224 (22.8 %) 37/171 (21.6 %) 14/53 (26.4 %) X2 = 1.051
- Always with the smallest diameter 30/224 (13.4 %) 24/171 (14 %) 6/53 (11.3 %) P = 0.591
- Randomly without assessment 0 0 0
Neck ultrasound for PDT used
- To guide needle, dilator and
cannula placement
25/118 (21.2 %) 18/95 (18.9 %) 7/23 (30.4 %) X2 = 5.966
- In suspected at-risk structure 81/118 (68.6 %) 69/95 (72.6 %) 12/23 (52.2 %) P = 0.051
- Both together 127118 (10.2 %) 8/95 (8.4 %) 4/23 (17.4 %)
Tracheostomy tube used
- Cuffed 118/257 (45.9 %) 89/194 (45.9 %) 29/63 (46 %)
- Cuffed with inner cannula 94/257 (36.6 %) 75/194 (38.7 %) 19/63 (30.2 %) X2 = 6.568
- Both 43/257 (16.7 %) 28/194 (14.4 %) 15/63 (23.8 %) P = 0.087
- Other 2/257 (0.8 %) 2/194 (1 %) 0
PDT percutaneous dilatational tracheostomy, ENT ear-nose-throat, ETT endotracheal tube, LMA laryngeal mask airway
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evaluate the differences between tracheostomy performed
in and outside Europe. Outside Europe: 1) the most used
tracheostomy was the ST performed in the ICU with more
involvement of ENT specialists; 2) informed consent for
tracheostomy was obtained more than in Europe; 3) the
intensivists more frequently performed one PDT, com-
pared to at least two or more in Europe; 4) PDT was per-
formed less in the first 7 days of admission; 5) a fiber optic
bronchoscope was used less often, and a diameter >6 mm
was used; 5) ST was chosen for patients with predicted
difficulties for PDT but also where there was insufficient
expertise in performing PDT; and 6) ETT puncture oc-
curred less frequently as intra-procedural complications
and there was increased incidence of subcutaneous em-
physema among early complications.
In line with previous surveys, SSDT was the most
popular technique in Europe and was mostly performed
by intensivists [5–7]. Surprisingly, ST was the most
popular tracheotomy technique outside Europe, and was
mainly performed by ENT specialists. PDT and ST were
easily performed, with a faster learning curve [5]. PDT is
a safe alternative to ST [13]. However, ENT specialistsand general surgeons preferred performing ST in the OR
compared to PDT at the bedside [14]. The percutaneous
approach was also a skill in the training of intensive care
physicians, whereas surgeons largely performed open
tracheostomies [15]. We think that the preference, back-
ground and training of physicians were responsible for
the choice of the tracheostomy technique in critically ill
patients. Indeed in this survey, ST was chosen more
frequently outside Europe because of the insufficient
expertise in performing PDT.
In our survey, prolonged mechanical ventilation followed
by difficult weaning were frequent indications for PDT.
This result was in line with previous surveys and reports
in the literature. Tracheostomy in the ICU was typically
indicated when patients were unlikely to undergo success-
ful extubation [16]. In this case, the risk of tracheostomy
outweighed the risk of prolonged translaryngeal intub-
ation [16]. The most frequent timing of PDT insertion in
this international survey was reported as 7–15 days; this is
in line with previous national surveys [5–12]. Recent trials
did not report any improvement in mortality after 30 days
comparing early (<4 days) and late (>10 days) tracheostomy
[17] or onset of pneumonia with the cutoff between early
Table 3 Response rate for the subgroup of surgical tracheostomies
Response rate Statistics
Total Europe Outside Europe
Where ST was performed
- ICU 106/281 (37.7 %) 74/208 (35.6 %) 32/73 (43.8 %) X2 = 3.220
- Operating room 166/281 (59.1 %) 128/208 (61.5 %) 38/73 (52.1 %) P = 0.200
- Other 9/281 (3.2 %) 6/208 (2.9 %) 3/73 (4.1 %)
Critically ill patients receiving
Tracheostomy in operating room
2797 (15.6 %)* 2022 (15.2 %) 775 (16.2 %) P = 0.642
Who performed ST in operating room
- Anesthesiologist 2/281 (0.7 %) 2/208 (1 %) 0
- Intensivist 7/281 (2.5 %) 6/208 (3 %) 1/73 (1.4 %)
- ENT specialist 165/281 (58.7 %) 113/208 (56.8 %) 52/73 (73.2 %)
- General surgeon 42/281 (14.9 %) 29/208 (14.6 %) 13/73 (18.3 %) X2 = 28.302
- Thoracic surgeon 17/281 (6 %) 15/208 (7.5 %) 2/73 (2.8 %) P = 0.000
- Plastic surgeon 1/281 (0.4 %) 0 1/73 (1.4 %)
- Maxillofacial surgeon 28/281 (10 %) 26/208 (13.1 %) 2/73 (2.8 %)
- Other 8/281 (2.8 %) 8/208 (4 %) 0
Why ST was chosen
- Insufficient expertise in PDT 22/281 (7.8 %) 9/208 (4.3 %) 13/73 (17.8 %)
- Reserved for patients with
predicted difficult PDT
187/281 (70.1 %) 153/208 (73.6 %) 44/73 (60.3 %) X2 = 20.207
- Predicted need for prolonged
tracheostomy
23/281 (8.2 %) 19/208 (9.1 %) 4/73 (5.5 %) P = 0.000
- Other 39/281 (13.9 %) 27/208 (13 %) 12/73 (16.4 %)
*Percentage calculated from total number of tracheostomies performed. ST surgical tracheostomy, ENT ear-nose-throat, PDT percutaneous
dilatational tracheostomy
Vargas et al. Critical Care  (2015) 19:291 Page 7 of 10and late tracheostomy at 13 days. In our opinion the timing
of PDT should be individualized according to patients’
needs.
Volume control ventilation was the most used in and
outside Europe. We found increased use of manual ven-
tilation outside Europe during the procedure. Sedation,
analgesia and neuromuscular blocking protocols were
mostly used in and outside Europe in line with the pre-
vious Italian survey [5]. Interestingly, local anesthesia
was more frequently provided outside Europe, probably
due to the high incidence of ST. However, the use of
general anesthesia with local anesthesia or of local
anesthesia alone differed in and outside Europe accord-
ing to the type of physician performing the tracheos-
tomy. Bronchoscopy during PDT was used more in
Europe than outside Europe. The frequent use of bron-
choscopy in Europe should be linked to more PDT being
performed. PDT is a blind technique for obtaining a sur-
gical airway [18], therefore the use of bronchoscopy may
add more safety to this procedure [19]. Bronchoscopy
outside Europe was used by 59 % of respondents, prob-
ably due to ST being used more frequently. ST is an
open procedure with direct visualization of procedural
steps [20]. In this case use of the bronchoscope may beavoided. In Europe the respondents chose a bronchoscope
with small diameters compared with those chosen outside
Europe. Minimizing the diameter of the bronchoscope
during PDT may reduce airway obstruction and hypercar-
bia or hypoxia [21, 22]. However, a new tool for PDT has
been recently proposed [23], which allows bronchoscopy
without compromising ventilation. In recent years, the
role of bronchoscopy in PDT has been questioned and the
use of neck ultrasound has been suggested [18]. However,
in this survey the neck ultrasound was used more fre-
quently in situations where other neck structures were
considered to be at increased risk of injury.
Bleeding controlled by compression and ETT puncture
were the most common intra-procedural and early com-
plications found in Europe, while there was a lower inci-
dence of ETT puncture outside Europe. Bleeding and
airway complications were the main complications re-
lated to PDT [24]. Outside Europe respondents reported
lower ETT puncture rates, likely because of the higher
incidence of open ST, allowing direct visualization of the
overall procedure.
Informed consent for PDT was obtained in 60 % of
cases and it was obtained more frequently outside Europe.
Indeed, informed consent before invasive and surgical
Table 4 Intraprocedural, early and late complications
Response rate Statistics
Total Europe Outside Europe
Most frequent intraprocedural complication
- Puncture posterior tracheal wall 2/257 (0.8 %) 2/194 (1 %) 0
- Puncture ETT 52/257 (20.2 %) 47/194 (24.2 %) 5/63 (7.9 %)
- Accidental extubation 17/257 (6.6 %) 15/194 (7.7 %) 2/63 (3.2 %)
- Difficult cannula placement 47/257 (18.3 %) 34/194 (17.5 %) 13/63 (20.6 %)
- Stoma not adequate 6/257 (2.3 %) 1/194 (0.5 %) 5/63 (7.9 %) X2 = 36.296
- False passage 4/257 (1.6 %) 2/194 (1 %) 2/63 (3.2 %) P = 0.000
- Convert the procedure 4/257 (1.6 %) 2/194 (1 %) 2/63 (3.2 %)
- Bleeding controlled by compression 89/257 (31.7 %) 63/194 (32.5 %) 26/63 (41.3 %)
- Bleeding requiring exploration 1/257 (0.4 %) 1/194 (0.5 %) 0
- Desaturation (<90 %) 16/257 (6.2 %) 11/194 (5.7 %) 5/63 (7.9 %)
- Pneumothorax 0 0 0
- Emphysema 1/257 (0.4 %) 1/194 (0.5 %) 0
- Other 18/257 (7 %) 15/194 (7.7 %) 3/63 (4.8 %)
Most frequent early complication
- Puncture posterior tracheal wall 1/257 (0.4 %) 1/194 (0.5 %) 0
- Puncture ETT 16/257 (6.2 %) 14/194 (7.2 %) 2/63 (3.2 %)
- Accidental extubation 3/257 (1.2 %) 3/194 (1.5 %) 0
- Difficult cannula placement 13/257 (5.1 %) 10/194 (5.2 %) 3/63 (4.8 %)
- Stoma not adequate 2/257 (0.8 %) 0 2/63 (3.2 %) X2 = 37.981
- False passage 2/257 (0.8 %) 2/194 (1 %) 0 P = 0.000
- Convert the procedure 2/257 (0.8 %) 2/194 (1 %) 0
- Bleeding controlled by compression 163/257 (63.4 %) 114/194 (58.8 %) 49/63 (77.8 %)
- Bleeding requiring exploration 9/257 (3.5 %) 9/194 (4.6 %) 0
- Desaturation (<90 %) 11/257 (4.3 %) 10/194 (5.2 %) 1/63 (1.6 %)
- Pneumothorax 1/257 (0.4 %) 1/194 (0.5 %) 0
- Emphysema 8/257 (3.1 %) 4/194 (2.1 %) 4/63 (6.3 %)
- Other 26/257 (10.1 %) 24/194 (12.4 %) 2/63 (3.2 %)
Most frequent late complication
- Bleeding controlled by compression 44/257 (17.1 %) 35/194 (18 %) 9/63 (14.3 %)
- Bleeding requiring exploration 15/257 (5.8 %) 13/194 (6.7 %) 2/63 (3.2 %) X2 = 3.555
- Stoma infection/inflammation 85/257 (33.1 %) 61/194 (31.4) 24/63 (38.1 %) P = 0.470
- Cannula extraction/malpositioning 54/257 (21 %) 40/194 (20.6 %) 14/63 (22.2 %)
- Other 59/257 (23 %) 45/194 (23.2 %) 14/63 (22.2 %)
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institutions [25]. In a national survey on informed consent
for tracheostomy in Italy we found that informed consent
for this procedure was provided by 65 % of patients
undergoing tracheostomy [26]. The practice of obtain-
ing informed consent varied in different countries
according to national legislation, history, culture, and
religion [27]. Tracheostomy is an elective procedure
committing the patients to a prolonged period of
recovery from critical illness. The choice of performingtracheostomy in critically ill patients should be carefully
discussed by ICU physicians and then with patients or the
patients’ families.
There appears to be considerable variability in trache-
ostomy practices in critically ill patients. For European
tracheostomy, our survey documented a general agree-
ment with respect to the indications, complications and
procedural steps for PDT and ST. The common method-
ology of practice is similar to published protocols, such
as the recent national Danish guideline for percutaneous
Vargas et al. Critical Care  (2015) 19:291 Page 9 of 10tracheostomy in the ICU [28]. Outside of Europe, such
respondents constituted approximately one third of par-
ticipants and their responses were heterogeneous and
frequently country-specific, illustrating that there are dif-
ferent styles of practice in international clinical practice.
The results of our survey may be an initial step towards
promoting a unified international practice guideline for
tracheostomy in the ICU.
Limitations
This study suffers from some potential limitations. We
found many differences between respondents in Europe
and outside Europe in the baseline characteristics of
the type of institution, type of intensive care, number of
ICU beds and different techniques performed. We also
performed statistical analysis according to the type of
intensive care, type of institution and different tech-
niques performed, but the results did not change.
Respondents from outside Europe represented only one
third of participants. For this reason we have added
weighting for the total number of respondents in
Europe and outside Europe to perform tests of statis-
tical significance. The respondents outside Europe were
heterogeneous, varying between different countries.
This survey was the first to look at the international
practice of tracheostomy. We were unable to further in-
vestigate other aspects of clinical practice, such as the
use of ultrasound and/or LMA, in order to avoid too
lengthy a survey.
Conclusions
PDT is used worldwide in critically ill patients, without
clinical guidelines to suggest the best practice [3]. This
survey represents the first snapshot of PDT international
clinical practice. This first global picture of current prac-
tices in regard to tracheostomy insertion demonstrates
considerable international variation in practice, suggest-
ing a need for greater standardization of approaches to
tracheostomy.
Key messages
 Percutaneous dilatational tracheostomy is one of the
most frequent procedure performed in the intensive
care unit
 Percutaneous dilatational tracheostomy is used
worldwide in critically ill patients, without clinical
guidelines to suggest the best practice
 This survey represents the first global picture of
current practices in performing tracheostomy
 This survey demonstrates considerable international
variation in practice, suggesting a need for greater
standardization of approaches to tracheostomy
insertionAdditional files
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